|
Market Closed -
Nasdaq
00:00:00 31/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 15.19 USD | -0.52% |
|
+9.83% | - |
| 09-21 | Attovia Therapeutics, Inc.(NasdaqGM:ATTO) added to S&P TMI Index | CI |
| 09-16 | Attovia Therapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 10:00 AM |
Company Valuation: Attovia Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2026 | 2027 | 2028 |
|---|---|---|---|
| Market Cap 1 | 693.4 | - | - |
| Change | - | - | - |
| Enterprise Value (EV) 1 | 314.5 | 407.3 | 185.5 |
| Change | - | 29.53% | -54.46% |
| P/E | -5.47x | -7.25x | -6.23x |
| PBR | 1.85x | 2.56x | 1.64x |
| PEG | -0.1x | 0.3x | -0.4x |
| Capitalization / Revenue | 1,499x | - | - |
| EV / Revenue | 680x | - | - |
| EV / EBITDA | -3.5x | -3.4x | -1.32x |
| EV / EBIT | -3.47x | -3.39x | -1.31x |
| EV / FCF | -3.35x | -3.57x | -1.4x |
| FCF Yield | -29.9% | -28% | -71.3% |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | -2.779 | -2.096 | -2.437 |
| Distribution rate | - | - | - |
| Net sales 1 | 0.4625 | - | - |
| EBITDA 1 | -89.96 | -119.9 | -140.3 |
| EBIT 1 | -90.61 | -120 | -141.3 |
| Net income 1 | -83.44 | -107.1 | -135.7 |
| Net Debt 1 | -379 | -286.1 | -507.9 |
| Reference price 2 | 15.19 | 15.19 | 15.19 |
| Nbr of stocks (in thousands) | 45,651 | - | - |
| Announcement Date | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.5x | 687.86x | -3.54x | - | 697M | |
| 16.97x | 6.42x | 12.3x | 1.76% | 64.38B | |
| 30.03x | 8.21x | 26.91x | 0.04% | 56.16B | |
| 37.32x | 6.62x | 19.78x | 0.87% | 54.16B | |
| 35.94x | 3.4x | 14.66x | -.--% | 45.33B | |
| 49.01x | 5.65x | 30.93x | -.--% | 42.25B | |
| -19.75x | 191.25x | -21.04x | -.--% | 40.78B | |
| 46.05x | 8.16x | 27.33x | -.--% | 33.8B | |
| 31.61x | 8.04x | 20.91x | 0.41% | 32.25B | |
| 27.18x | 5.72x | 14.84x | -.--% | 23.57B | |
| Average | 24.89x | 93.13x | 14.31x | 0.34% | 39.34B | |
| Weighted average by Cap. | 27.73x | 26.88x | 16.35x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ATTO Stock
- Valuation Attovia Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
